» Articles » PMID: 28073899

Paper-Based MicroRNA Expression Profiling from Plasma and Circulating Tumor Cells

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2017 Jan 12
PMID 28073899
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Molecular characterization of circulating tumor cells (CTCs) holds great promise for monitoring metastatic progression and characterizing metastatic disease. However, leukocyte and red blood cell contamination of routinely isolated CTCs makes CTC-specific molecular characterization extremely challenging.

Methods: Here we report the use of a paper-based medium for efficient extraction of microRNAs (miRNAs) from limited amounts of biological samples such as rare CTCs harvested from cancer patient blood. Specifically, we devised a workflow involving the use of Flinders Technology Associates (FTA) Elute Card with a digital PCR-inspired "partitioning" method to extract and purify miRNAs from plasma and CTCs.

Results: We demonstrated the sensitivity of this method to detect miRNA expression from as few as 3 cancer cells spiked into human blood. Using this method, background miRNA expression was excluded from contaminating blood cells, and CTC-specific miRNA expression profiles were derived from breast and colorectal cancer patients. Plasma separated out during purification of CTCs could likewise be processed using the same paper-based method for miRNA detection, thereby maximizing the amount of patient-specific information that can be derived from a single blood draw.

Conclusions: Overall, this paper-based extraction method enables an efficient, cost-effective workflow for maximized recovery of small RNAs from limited biological samples for downstream molecular analyses.

Citing Articles

Dynamic altruistic cooperation within breast tumors.

Bin Masroni M, Lee K, Lee V, Ng S, Law C, Poon K Mol Cancer. 2023; 22(1):206.

PMID: 38093346 PMC: 10720132. DOI: 10.1186/s12943-023-01896-7.


Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities.

Yang Y, Giret T, Cote R Cancers (Basel). 2021; 13(11).

PMID: 34072844 PMC: 8198976. DOI: 10.3390/cancers13112723.


Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.

Kyriazi A, Papiris E, Kitsos Kalyvianakis K, Sakellaris G, Baritaki S Int J Mol Sci. 2020; 21(18).

PMID: 32932969 PMC: 7556003. DOI: 10.3390/ijms21186658.


An ultraportable and versatile point-of-care DNA testing platform.

Xu H, Xia A, Wang D, Zhang Y, Deng S, Lu W Sci Adv. 2020; 6(17):eaaz7445.

PMID: 32426466 PMC: 7176422. DOI: 10.1126/sciadv.aaz7445.


Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?.

Braun M, Markiewicz A, Kordek R, Sadej R, Romanska H Cancers (Basel). 2019; 11(2).

PMID: 30691008 PMC: 6406427. DOI: 10.3390/cancers11020143.